Bethesda (1)

Rochester (1)

Glomerulonephritis, Membranoproliferative (2)

Lupus Nephritis (1)

Completed (2)

phase 1 (1)

phase 2 (1)

Mayo Clinic (1)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)

bg9588 (1)

rituximab (1)

drug (2)

NIH (1)

Other (1)

Interventional (2)

glomerulonephritis, membranoproliferative

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Jan 15, 2013

Completed

Bethesda, Maryland

National Institute of Arthritis and Musculoskeletal and Skin Dis

Mar 3, 2008